<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50323">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01969929</url>
  </required_header>
  <id_info>
    <org_study_id>UKK-13-247</org_study_id>
    <secondary_id>13-247</secondary_id>
    <nct_id>NCT01969929</nct_id>
  </id_info>
  <brief_title>Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy</brief_title>
  <acronym>20Gvs23G</acronym>
  <official_title>Comparison of Postoperative Aqueous Flare After 20G Versus 23G Pars Plana Vitrectomy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Cologne</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Cologne</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare postoperative inflammation and breakdown of blood-retinal barrier as measured by
      a laser flare-cell meter in 20G versus 23G vitrectomy.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">October 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>Alteration of aqueous flare between preoperative and 3-week-postoperative time point</measure>
    <time_frame>3 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual acuity change</measure>
    <time_frame>3 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Closure of Macular hole</measure>
    <time_frame>3 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <other_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>3 weeks</time_frame>
    <safety_issue>No</safety_issue>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Macular Hole</condition>
  <condition>Macular Pucker</condition>
  <arm_group>
    <arm_group_label>20G</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>20G vitrectomy with scleral and conjunctival sutures for closure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>23G</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>23G transconjunctival sutureless vitrectomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>20G Vitrectomy</intervention_name>
    <arm_group_label>20G</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>23G vitrectomy</intervention_name>
    <arm_group_label>23G</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        age &gt; 18 years macular hole macular pucker willing to perform follow up written signed
        consent

        Exclusion Criteria:

        other relevant eye disease: retinal detachment, provect cataract, diabetic retinopathy,
        AMD, relevant glaucoma, pre-surgery except for cataract surgery
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sascha Fauser, MD, PhD</last_name>
    <phone>+492214780</phone>
    <phone_ext>7719</phone_ext>
    <email>sascha.fauser@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Philipp S Muether, MD, PhD</last_name>
    <phone>+492214780</phone>
    <phone_ext>4328</phone_ext>
    <email>philmuether@mac.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Center of Ophthalmology, University of Cologne</name>
      <address>
        <city>Cologne</city>
        <state>NRW</state>
        <zip>50937</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sascha Fauser, MD, PhD</last_name>
      <phone>+492214780</phone>
      <phone_ext>7719</phone_ext>
      <email>sascha.fauser@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 21, 2013</lastchanged_date>
  <firstreceived_date>October 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Cologne</investigator_affiliation>
    <investigator_full_name>Sascha Fauser</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Retinal Perforations</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
